PPAR agonists are a class of nuclear receptors that play a crucial role in regulating lipid metabolism, glucose homeostasis, and inflammatory responses, making them a key molecular target for the treatment of cholestatic liver disease, such as PBC (Colapietro et al., 2023). Here, PPARA is linked to primary biliary cholangitis.